STAT3 and gastric cancer: It was also reported that Src activity was markedly increased in trastuzumab resistant gastric cancer cells [53] and that activated Src was capable of interacting with and activating Stat3 in fibroblasts [54], implying that other signaling pathways may also be involved in development of trastuzumab resistance.